Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|October 13, 2018
A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526)Juanita M Crook, Peixin Zhang, Thomas M Pisansky, et al.International Journal of Radiation Oncology, Biology, Physics|October 3, 2022
GEC-ESTRO (ACROP)-ABS-CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the VaginaMitchell Kamrava, Eric Leung, Francois Bachand, et al.Cancer Epidemiology|May 14, 2016
A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathwaysAbul Kalam Azad, Isabelle Bairati, Xin Qiu, et al.JAMA Oncology|March 16, 2018
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical TrialJeff M Michalski, Jennifer Moughan, James Purdy, et al.International Journal of Radiation Oncology, Biology, Physics|November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.The Journal of Urology|July 25, 2025
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME StudyBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.Endocrine Oncology (Bristol, England)|July 3, 2026
Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancerMathew Gorman, Nawaid Usmani, Michael N Pollak, et al.JAMA Oncology|March 14, 2024
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical TrialMark K Buyyounouski, Stephanie L Pugh, Ronald C Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal CancerCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.International Journal of Radiation Oncology, Biology, Physics|December 17, 2021
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126William A Hall, Snehal Deshmukh, Deborah W Bruner, et al.Pageof 8